Dare Bioscience, Inc. — Director's Dealing 2014

Oct 31, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-10-29

Reporting Person: FRIEDMAN PAUL A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-29	Stock Option (right to buy)	$4.36	A	100000	Acquired	2024-10-28	Common Stock (100000)	Direct

Footnotes

F1: This option was granted on October 29, 2014. The option will fully vest as of October 29, 2015.